Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant KIT D816 isoforms prevalent in systemic mastocytosis and core binding factor leukemia

Kampa-Schittenhelm, Kerstin Maria; Frey, Julia; Haeusser, Lara A.; Illing, Barbara; Pavlovsky, Ashly A.; Blumenstock, Gunnar; Schittenhelm, Marcus Matthias

dc.contributor.author	Kampa-Schittenhelm, Kerstin Maria
dc.contributor.author	Frey, Julia
dc.contributor.author	Haeusser, Lara A.
dc.contributor.author	Illing, Barbara
dc.contributor.author	Blumenstock, Gunnar
dc.contributor.author	Schittenhelm, Marcus Matthias
dc.date.accessioned	2019-04-23T09:29:12Z
dc.date.available	2019-04-23T09:29:12Z
dc.date.issued	2017
dc.identifier.issn	1949-2553
dc.identifier.uri	http://hdl.handle.net/10900/87944
dc.language.iso	en	de_DE
dc.publisher	Impact Journals Llc	de_DE
dc.relation.uri	http://dx.doi.org/10.18632/oncotarget.19970	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant KIT D816 isoforms prevalent in systemic mastocytosis and core binding factor leukemia	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_00791
utue.publikation.seiten	82897-82909	de_DE
utue.personen.roh	Kampa-Schittenhelm, Kerstin Maria
utue.personen.roh	Frey, Julia
utue.personen.roh	Haeusser, Lara A.
utue.personen.roh	Illing, Barbara
utue.personen.roh	Pavlovsky, Ashly A.
utue.personen.roh	Blumenstock, Gunnar
utue.personen.roh	Schittenhelm, Marcus Matthias
dcterms.isPartOf.ZSTitelID	Oncotarget	de_DE
dcterms.isPartOf.ZS-Issue	47	de_DE
dcterms.isPartOf.ZS-Volume	8	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE